IL17A and colorectal carcinoma: Although macrophages, due to their exceptional plasticity during colitis and cancer progression, could be pleiotropic orchestrators for pro- or antitumor immunity (17, 29), IL23 and IL17A are known promoters of early CRC (9, 12).